Four more experimental drugs for amyotrophic lateral sclerosis (ALS) have failed to hit the primary endpoint in the phase 2/3 HEALEY ALS basket trial, which is trying to accelerate the search for new ...
ALS patient Brad Smith controls computers with thoughts using Neuralink's brain chip, bypassing eye-tracking limitations for ...
Electrical signals called far-field potentials may help track disease progression in SMA, a new study suggests.